amphetamine has been researched along with Cardiac Diseases in 11 studies
Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In conclusion, the current study revealed that the S-100β serum level could be used as an outcome predictor in hospital admission cases due to toxic amphetamine exposure and offers an idea about the cardiac and neuronal involvement." | 5.62 | Potential Role of Serum S-100β Protein as a Predictor of Cardiotoxicity and Clinical Poor Outcome in Acute Amphetamine Intoxication. ( Al-Asmari, AZ; Elsheikh, E; Gameel, DE; Sharif, AF, 2021) |
| " In conclusion, the current study revealed that the S-100β serum level could be used as an outcome predictor in hospital admission cases due to toxic amphetamine exposure and offers an idea about the cardiac and neuronal involvement." | 1.62 | Potential Role of Serum S-100β Protein as a Predictor of Cardiotoxicity and Clinical Poor Outcome in Acute Amphetamine Intoxication. ( Al-Asmari, AZ; Elsheikh, E; Gameel, DE; Sharif, AF, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (72.73) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, SH | 1 |
| Pai, PY | 1 |
| Hsu, CH | 1 |
| Marthandam Asokan, S | 1 |
| Tsai, BC | 1 |
| Weng, WT | 1 |
| Kuo, WW | 1 |
| Shih, TC | 1 |
| Kao, HC | 1 |
| Chen, WS | 1 |
| Huang, CY | 1 |
| Sharif, AF | 1 |
| Elsheikh, E | 1 |
| Al-Asmari, AZ | 1 |
| Gameel, DE | 1 |
| Carvalho, M | 1 |
| Carmo, H | 1 |
| Costa, VM | 1 |
| Capela, JP | 1 |
| Pontes, H | 1 |
| Remião, F | 1 |
| Carvalho, F | 1 |
| Bastos, Mde L | 1 |
| HALPERN, BN | 1 |
| MORARD, JC | 1 |
| DRUDI-BARACCO, C | 1 |
| ROSENBLUM, I | 1 |
| WOHL, A | 1 |
| STEIN, AA | 1 |
| RUSSEK, HI | 1 |
| Throne, ML | 1 |
| Greenblatt, DJ | 1 |
| Shader, RI | 1 |
| Asher, WL | 1 |
| Prinzmetal, M | 1 |
| Williams, RV | 1 |
2 reviews available for amphetamine and Cardiac Diseases
| Article | Year |
|---|---|
Toxicity of amphetamines: an update.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Chemical and | 2012 |
Drug therapy reviews: rational use of psychotropic drugs. III. Major tranquilizers.
Topics: Adrenergic alpha-Agonists; Adult; Alcoholism; Amphetamine; Antiemetics; Antipsychotic Agents; Body T | 1974 |
9 other studies available for amphetamine and Cardiac Diseases
| Article | Year |
|---|---|
Estimating the impact of drug addiction causes heart damage.
Topics: Adult; Aged; Amphetamine; Biomarkers; Heart Diseases; Heart Injuries; Heroin; Heroin Dependence; Hum | 2023 |
Potential Role of Serum S-100β Protein as a Predictor of Cardiotoxicity and Clinical Poor Outcome in Acute Amphetamine Intoxication.
Topics: Adolescent; Adult; Amphetamine; Biomarkers; Cardiotoxicity; Central Nervous System Stimulants; Cross | 2021 |
[Protective effect of reserpine on the lesions in acute myocardial degeneration induced by DL-amphetamine and the suppression of this action by monoamine oxidase inhibitors].
Topics: Amphetamine; Amphetamines; Behavior; Cardiomyopathies; Heart Diseases; Monoamine Oxidase Inhibitors; | 1962 |
STUDIES IN CARDIAC NECROSIS. I. PRODUCTION OF CARDIAC LESIONS WITH SYMPATHOMIMETIC AMINES.
Topics: Amphetamine; Amphetamines; Animals; Cats; Cricetinae; Dogs; Ephedrine; Epinephrine; Heart Diseases; | 1965 |
CONTROL OF OBESITY IN THE CARDIAC PATIENT.
Topics: Amphetamine; Appetite Depressants; Arrhythmias, Cardiac; Biomedical Research; Coronary Disease; Diet | 1965 |
The use of psychotropic agents in heart disease.
Topics: Amphetamine; Antidepressive Agents; Antipsychotic Agents; Heart Diseases; Humans; Phenothiazines | 1974 |
Mortality rate in patients receiving "diet pills".
Topics: Adolescent; Adult; Age Factors; Aged; Amphetamine; Cathartics; Child; Digitalis; Diuretics; Drug Syn | 1972 |
The origin of the effective treatment of cardiac shock.
Topics: Amphetamine; Heart Diseases; Humans; Phenylephrine; Shock | 1966 |
Exercise and the heart.
Topics: Adolescent; Adult; Amphetamine; Blood Pressure; Collateral Circulation; Coronary Vessels; Female; He | 1970 |